Manufacturer |
ProSci
|
Category |
|
Type |
Antibody Polyclonal |
Specific against |
Human, Mouse, Rat |
Format |
Liquid |
Applications |
WB, ELISA |
Amount |
0.02 mg |
Host |
Rabbit |
Item no. |
PRS-2225-0.02mg |
eClass 6.1 |
32160702 |
eClass 9.0 |
32160702 |
Available |
|
Shipping |
blue ice or RT |
By Research Area |
Apoptosis |
Immunogen |
Nop30 antibody was raised against a 14 amino acid synthetic peptide from near the carboxy terminus of human Nop30.
The immunogen is located within the last 50 amino acids of Nop30. |
Applications |
Nop30 antibody can be used for detection of Nop30 by Western blot at 0.5 - 2 μ g/mL. Antibody can also be used for immunohistochemistry starting at 0.5 μ g/mL.
Antibody validated: Western Blot in mouse samples. All other applications and species not yet tested. |
Positive Control 1 |
Cat. No. 1407 - Mouse Skeletal Muscle Tissue Lysate |
Purification |
Nop30 Antibody is affinity chromatography purified via peptide column. |
Clonality |
Polyclonal |
Isotype |
IgG |
Conjugate |
Unconjugated |
Buffer |
Nop30 Antibody is supplied in PBS containing 0.02% sodium azide. |
Concentration |
1 mg/ml |
Storage Conditions |
Nop30 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures. |
Related Products |
Cat. No. 2225P – Nop30 Peptide |
Disclaimer |
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only. |
Modifications |
None |
Ncbi Official Symbol |
NOL3 |
Accession # |
NP_001171986 |
Protein Gi # |
15215394 |
Ncbi Gene Id # |
8996 |
User Note |
Optimal dilutions for each application to be determined by the researcher. |
Ncbi Official Symbol |
NOL3 |
Ncbi Official Full Name |
nucleolar protein 3 (apoptosis repressor with CARD domain) |
Ncbi Organism |
Homo sapiens |
Swissprot # |
O60936 |
Background |
Nop30 Antibody: Apoptosis, also known as programmed cell death, plays major roles in development and normal tissue turnover in addition to tumor formation. Apoptosis is regulated by death domain (DD) and/or caspase recruitment domain (CARD) containing molecules and the caspase family of proteases. CARD domain containing cell death regulators include RAIDD, Apaf-1, caspase-9, and caspase-2. A novel CARD domain containing protein was recently identified and designated ARC for apoptosis repressor with CARD. An alternate splicing isoform of ARC was identified as Nop30. While ARC interacts with caspase-2 and -8 and suppresses apoptosis induced by cell death adapters FADD and TRADD and by cell death receptors Fas, TNFR-1 and DR3, Nop30 multimerizes and binds to the splicing factor SRp30c and may act to influence alternative splice site selection in vivo. The Nop30 antibody will not detect ARC protein. |
Background References 1 |
Jin Z and El Deiry WS. Overview of cell death signaling pathways. Cancer Biol. Ther. 2004; 4:139-63. |
Background References 2 |
Koseki T, Inohara N, Chen S, et al. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc. Natl. Acad. Sci. USA 1998; 95:5156-60. |
Background References 3 |
Stoss O, Schwaiger FW, Cooper TA, et al. Alternative splicing determines the intracellular localization of the novel nuclear protein Nop30 and its interaction with the splicing factor SRp30c. J. Biol. Chem.1999; 274:10951-62 |
1st Image Caption |
Western blot analysis of Nop30 in mouse muscle tissue lysate with Nop30 antibody at (A) 0.5, (B) 1 and (C) 2 μ g/mL. |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.